Gaps in using bronchodilators, inhaled corticosteroids and influenza vaccine among 23 high- and low-income sites
| Autor: | Gnatiuc, L, Buist, AS, Kato, BS, Janson, C, Aït-Khaled, N, Nielsen, R, Koul, PA, Nizankowska-Mogilnicka, E, Obaseki, D, Idolor, LF, Harrabi, I, Burney, PGJ, Vollmer, W, Gillespie, S, McBurnie, M, Jithoo, A, Coton, S, Azhar, H, Zhong, NS, Liu, SM, Lu, JC, Ran, PX, Wang, DL, Zheng, JP, Zhou, YM, Kocabas, A, Hancioglu, A, Hanta, I, Kuleci, S, Turkyilmaz, AS, Umut, S, Unalan, T, Studnicka, M, Dawes, T, Lamprecht, B, Schirhofer, L, Bateman, E, Adams, D, Barnes, E, Freeman, J, Hayes, A, Hlengwa, S, Johannisen, C, Koopman, M, Louw, I, Ludick, I, Olckers, A, Ryck, J, Storbeck, J, Gislason, T, Benedikdtsdottir, B, Jorundsdottir, K, Gudmundsdottir, L, Gudmundsdottir, S, Gundmundsson, G, Frey, J, Harat, R, Mejza, F, Nastalek, P, Pajak, A, Skucha, W, Szczeklik, A, Twardowska, M, Welte, T, Bodemann, I, Geldmacher, H, Schweda-Linow, A, Gulsvik, A, Endresen, T, Svendsen, L, Tan, WC, Wang, W, Mannino, DM, Cain, J, Copeland, R, Hazen, D, Methvin, J, Dantes, RB, Amarillo, L, Berratio, LU, Fernandez, LC, Francisco, NA, Garcia, GS, De Guia, TS, Naval, SS, BOLD Collaboration |
|---|---|
| Přispěvatelé: | Çukurova Üniversitesi |
| Rok vydání: | 2015 |
| Předmět: |
Pulmonary and Respiratory Medicine
Low income Influenza vaccine business.industry Cross-sectional study Determinants for use Inhaled corticosteroids medicine.disease Prevention of exacerbations Vaccination Copd and asthma treatments Infectious Diseases Multicenter study Low and middle income countries Environmental health Immunology medicine business Essential respiratory medications Asthma |
| Zdroj: | The International Journal of Tuberculosis and Lung Disease. 19:21-30 |
| ISSN: | 1815-7920 1027-3719 |
| DOI: | 10.5588/ijtld.14.0263 |
| Popis: | Background Increasing access to essential respiratory medicines and influenza vaccination has been a priority for over three decades. Their use remains low in low- and middle-income countries (LMICs), where little is known about factors influencing use, or about the use of influenza vaccination for preventing respiratory exacerbations. Methods We estimated rates of regular use of bronchodilators, inhaled corticosteroids and influenza vaccine, and predictors for use among 19 000 adults in 23 high-income countries (HICs) and LMIC sites. Results Bronchodilators, inhaled corticosteroids and influenza vaccine were used significantly more in HICs than in LMICs, after adjusting for similar clinical needs. Although they are used more commonly by people with symptomatic or severe respiratory disease, the gap between HICs and LMICs is not explained by the prevalence of chronic obstructive pulmonary disease or doctor-diagnosed asthma. Site-specific factors are likely to influence use differently. The gross national income per capita for the country is a strong predictor for use of these treatments, suggesting that economics influence under-treatment. Conclusion We still need a better understanding of determinants for the low use of essential respiratory medicines and influenza vaccine in low-income settings. Identifying and addressing these more systematically could improve the access and use of effective treatments. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|